The concept of apolipoprotein-defined lipoprotein families and its clinical significance (Q35549917)

8 August 2017

1 reference

title

The concept of apolipoprotein-defined lipoprotein families and its clinical significance (English)

1 reference

Cardiology and cardiovascular medicine

8 August 2017

1 reference

https://api.crossref.org/works/10.1007/S11883-003-0036-8

17 March 2024

author name string

Petar Alaupovic

series ordinal

1

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14525679

17 March 2024

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

http://link.springer.com/content/pdf/10.1007/s11883-003-0036-8.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11883-003-0036-8

http://link.springer.com/article/10.1007/s11883-003-0036-8/fulltext.html

17 March 2024

1 reference

https://api.crossref.org/works/10.1007/S11883-003-0036-8

http://link.springer.com/content/pdf/10.1007/s11883-003-0036-8

17 March 2024

1 reference

https://api.crossref.org/works/10.1007/S11883-003-0036-8

Current Atherosclerosis Reports

17 March 2024

published in

1 reference

8 August 2017

5

1 reference

8 August 2017

6

1 reference

8 August 2017

459-467

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-003-0036-8

8 August 2017

0 references

cites work

Lipoprotein heterogeneity and apolipoprotein B metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0036-8

Apolipoproteins B, C-III and E in two major subpopulations of low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0036-8

Selective uptake of cholesteryl esters from high-density lipoprotein-derived LpA-I and LpA-I:A-II particles by hepatic cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0036-8

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0036-8

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0036-8

Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates

21 January 2018

1 reference

12 December 2020

Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia

1 reference

12 December 2020

A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Apolipoprotein A-I containing lipoproteins in coronary artery disease

1 reference

12 December 2020

Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins.

1 reference

12 December 2020

The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease

1 reference

12 December 2020

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

1 reference

12 December 2020

Lowering of HDL2-cholesterol and lipoprotein A-I particle levels by increasing the ratio of polyunsaturated to saturated fatty acids

1 reference

12 December 2020

Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells.

1 reference

12 December 2020

Composition of plasma ApoA-I-containing lipoprotein particles in children and adults

1 reference

12 December 2020

Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes

1 reference

12 December 2020

Study of lipoprotein particles LpAI and LpAI:AII in patients before coronary bypass surgery

1 reference

12 December 2020

Identification of apoB-containing lipoprotein families in NIDDM

1 reference

12 December 2020

Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition

1 reference

12 December 2020

Heterogeneity of very-low-density lipoprotein metabolism in hyperlipidemic subjects

1 reference

12 December 2020

Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity

1 reference

12 December 2020

New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism

1 reference

12 December 2020

Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2

1 reference

12 December 2020

Distribution of subclasses of HDL containing apoA-I without apoA-II (LpA-I) in normolipidemic men and women.

1 reference

12 December 2020

Effects of a diet restricted in saturated fatty acids and cholesterol on the composition of apolipoprotein A-I--containing lipoprotein particles in the fasting and fed states.

1 reference

12 December 2020

The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial

1 reference

12 December 2020

Postprandial lipemia differentially influences high density lipoprotein subpopulations LpAI and LpAI,AII.

1 reference

12 December 2020

Human serum lipoproteins and their interrelationships

1 reference

12 December 2020

Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction

1 reference

12 December 2020

Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy

1 reference

12 December 2020

Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay

1 reference

12 December 2020

Influence of diet on the plasma levels and distribution of ApoA-I-containing lipoprotein particles

1 reference

12 December 2020

The Plasma Lipoproteins

1 reference

12 December 2020

Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia

1 reference

12 December 2020

Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease

1 reference

12 December 2020

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

1 reference

12 December 2020

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

12 December 2020

Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin:cholesterol acyltransferase

1 reference

12 December 2020

Selective isolation of human plasma low-density lipoprotein particles containing apolipoproteins B and E by use of a monoclonal antibody to apolipoprotein B

1 reference

12 December 2020

Evidence that triglycerides are an independent coronary heart disease risk factor

1 reference

12 December 2020

Change in alpha1 HDL concentration predicts progression in coronary artery stenosis

1 reference

12 December 2020

Distribution of cholesterol and apolipoprotein A-I and A-II in human high density lipoprotein subfractions separated by CsCl equilibrium gradient centrifugation: evidence for HDL subpopulations with differing A-I/A-II molar ratios

1 reference

12 December 2020

Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E

1 reference

12 December 2020

IDL, VLDL, chylomicrons and atherosclerosis

1 reference

12 December 2020

Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells

1 reference

12 December 2020

Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins.

1 reference

12 December 2020

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

1 reference

12 December 2020

Separation and identification of apo-B-containing lipoprotein particles in normolipidemic subjects and patients with hyperlipoproteinemias.

1 reference

12 December 2020

Differential turbidimetric assay for subpopulations of lipoproteins containing apolipoprotein A-I

1 reference

12 December 2020

Blood lipids, lipid-related measures, and the risk of atherosclerotic cardiovascular disease

1 reference

12 December 2020

Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels

1 reference

12 December 2020

Phenotyping. On reaching base camp (1950-1975).

1 reference

12 December 2020

Ljpoprotein-containlng apolipoprotein A-l: sex-related quantitative and qualitative changes in this lipoprotein subspecies after ingestion of fat

1 reference

12 December 2020

Composition and concentration of apolipoproteins in very-low-and low-density lipoproteins of normal human plasma.

1 reference

12 December 2020

In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II

1 reference

12 December 2020

David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins

1 reference

12 December 2020

Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins

1 reference

12 December 2020

High-density lipoprotein turnover

1 reference

12 December 2020

Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease

1 reference

12 December 2020

In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II

1 reference

12 December 2020

Cholesterol reduction yields clinical benefit: impact of statin trials

1 reference

12 December 2020

The analysis of human serum lipoprotein distributions

1 reference

12 December 2020

LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients

1 reference

12 December 2020

The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease

1 reference

12 December 2020

A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition

1 reference

12 December 2020

Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families

1 reference

12 December 2020

Lipoproteins in atherosclerosis.

1 reference

12 December 2020

Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie

35

26

573

W März

1988

1 reference

https://api.crossref.org/works/10.1007/S11883-003-0036-8

17 March 2024

Identifiers

1 reference

release_24hz4piwczhktmtuh5vyycg2wy

8 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/24hz4piwczhktmtuh5vyycg2wy

24 November 2022

mapped directly with Wikidata item

1 reference